ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

Low vitamin D levels predict ED in diabetics

The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage

 
Print Page
Email Article

FDA Backs New Alzheimer’s Drug: Memantine

  [ 224 votes ]   [ Discuss This Article ]
www.ProHealth.com • September 25, 2003


WASHINGTON, Sept. 25 — A drug long used in Germany to ease the ravages of Alzheimer’s disease took a step toward the U.S. market on Wednesday when government scientists backed memantine as the first treatment specifically for late stages of the mind-stealing disease.

BUT THE Food and Drug Administration’s advisers struggled with how much benefit memantine actually offers, and if it could give false hope to families of the most severely ill patients.

“I believe this to be a very small effect size,” cautioned the panel’s chairwoman, Dr. Claudia Kawas of the University of California, Irvine. “The entire committee has certain concerns.”

When it comes to benefit for the most severe Alzheimer’s patients, “I’m very unimpressed,” added Dr. Roger Packer, a neuroscientists in Washington.

Still, the FDA panel voted unanimously that memantine does offer some benefit to people with moderate to severe Alzheimer’s symptoms, and is safe enough to try.

If the FDA ultimately agrees, memantine would mark an important step in Alzheimer’s therapy. The nation’s four other Alzheimer’s medications are designated for early stages of the disease, and they work on a different brain chemical than memantine. The new drug could let doctors, for the first time, prescribe drug combinations in hopes of better results.

The FDA is not bound by its advisers’ recommendations but typically follows them. A decision could come as early as this fall.

Families out of options are anxiously awaiting memantine; many now try to buy supplies overseas via the Internet. The drug’s U.S. marketer, Forest Laboratories, says it receives over 1,000 calls a month from families desperate to buy it in this country.

“These are priceless moments regained,” said Barry Cooper of Arlington, Va., who told the FDA panel that his wife, Linda, talks more and regained some small skills since starting memantine bought abroad.

“Every month can count,” he added, urging that FDA act quickly.

Memantine is not miraculous, even company-affiliated researchers acknowledged. But it can help stabilize patients so that they maintain certain functions for a few months longer, said Dr. Pierre Tariot of the University of Rochester, who led one of the critical studies.

He said studies suggest memantine gives some patients the ability go to the toilet independently for six more months, “and that’s very important.”

It is not known if memantine might help in earlier stages of Alzheimer’s. Studies of that question are in progress.

Forest has not announced a projected U.S. price. One Internet site advertises the drug for about $146 for a month’s supply.

About 4 million Americans have Alzheimer’s, and a million of them are believed to suffer severe symptoms. There is no known cure or prevention.

A six-month study of patients with moderate to severe Alzheimer’s symptoms found those given memantine worsened significantly slower — by one measure, at half the pace, according to researchers. In a second study, patients taking the older Alzheimer’s drug Aricept found added benefit when they took memantine, too.

Some patients reported actual improvements in memory and thinking skills. For the majority, however, the drug simply slowed the pace of deterioration.

FDA panelists could not say how much benefit patients got. More confusing, when FDA’s scientists looked at just the most severely ill patients, in one study memantine seemed to have no effect and only moderately ill patients were helped.

FDA’s advisers could not say how the average doctor would know who should get the pill and when the medication would be a waste of time.

Today’s Alzheimer’s drugs — Aricept, Exelon, Reminyl and Cognex — delay the breakdown of a brain chemical called acetylcholine that is vital for nerve cells to communicate. Memantine blocks excess amounts of another brain chemical, called glutamate, that can damage or kill nerve cells.

Memantine has been sold in Germany for two decades to treat various brain diseases, with few, mild side effects reported to date. In 1999, the first large studies suggesting memantine helped advanced Alzheimer’s were published, prompting U.S. research.

German drug-maker Merz Pharmaceuticals last year won Europe-wide approval of memantine for advanced Alzheimer’s, and Forest Laboratories filed for FDA approval in late December.

© 2003 Associated Press. All rights reserved.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Energy NADH™ 12.5mg Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map